SHAUGHNESSY TAYLOR: Open Payments
NPI 1649022401 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,834 in 86 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $788 · 2025 $1,834
Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $426 |
| Lilly USA, LLC | 15 | $331 |
| ABBVIE INC. | 10 | $225 |
| Novo Nordisk Inc | 7 | $152 |
| PFIZER INC. | 5 | $90 |
| Exact Sciences Corporation | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Janssen Pharmaceuticals, Inc | 2 | $64 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
Products named: MOUNJARO, AIRSUPRA, VRAYLAR, FARXIGA, REXULTI, Ozempic, BREZTRI, SPRAVATO.
Industry payments across PA — which companies pay providers there.
